NEURODEGENERNATION RESEARCH PROGRAM (NRP)

神经退行性研究计划 (NRP)

• 批准号: 8357110
• 负责人: KARAM F.A. SOLIMAN
• 金额: $ 44.48万
• 依托单位: FLORIDA AGRICULTURAL AND MECHANICAL UNIV
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-06-01 至 2012-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8357110
• 关键词: Academic Training; African American; Area; Data; Disease; Educational workshop; Elderly; Faculty; Florida; Funding; General Population; Goals; Grant; Health; Human; Institution; Mainstreaming; Mentors; Minority; Molecular Neurobiology; National Center for Research Resources; Nerve Degeneration; Neurodegenerative Disorders; Neurosciences; Pharmacologic Substance; Pharmacy facility; Pilot Projects; Population; Positioning Attribute; Principal Investigator; Productivity; Publishing; Research; Research Infrastructure; Research Personnel; Research Project Grants; Resources; Science; Source; Training; United States National Institutes of Health; Universities; cellular imaging; college; cost; innovation; multidisciplinary; neurochemistry; programs; receptor binding; research and development; research facility; supported housing

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. ABSTRACT The major goals of the RCMI NPR are to establish Neurodegeneration Research Program (NRP), to enhance the infrastructure in this area of research at Florida A&M University and to increase research productivity of its faculty. The potential impact of establishing a Neurodegeneration research program cannot be overstated. Neurodegenerative diseases have a major impact on the health of the general public in and the elderly population in particular. Moreover, this program will have a major impact toward increasing the number of minority neuroscientists in the Nation. FAMU College of Pharmacy and Pharmaceutical Sciences is the leading institution, nationwide, in training African Americans with PhD's in pharmaceutical sciences and in the area of neuroscience. Therefore, the purpose of this application is to develop Neurodegeneration research by adding onto the human infrastructure and research resources that already exist. The long-term objectives are to establish an innovative and multidisciplinary program focusing on Neurodegeneration. The specific aims are to: 1) support a Neurodegeneration research pilot project of a junior FAMU investigator. The project is expected to generate data that will be published, help establish the investigator and allow opportunities for faculty to seek and obtain independent research funds; 2) support the development of research facilities to increase innovation of Neurodegeneration diseases research. Research facilities will include: a) Molecular Neurobiology, b) Cellular Imaging, and c) Neurochemistry/Receptors binding; 3) offer in-house support to start Neurodegeneration research projects; and 4) enhance the research capabilities of Neurodegeneration investigators that will put them in a position to compete for mainstream funding through the establishment of internal and external mentoring program and provide training and academic interaction in the form of mini-sabbatical, seminars and workshops.

该副本是利用资源的众多研究子项目之一 由NIH/NCRR资助的中心赠款提供。对该子弹的主要支持 而且，副投影的主要研究员可能是其他来源提供的 包括其他NIH来源。 列出的总费用可能 代表subproject使用的中心基础架构的估计量， NCRR赠款不直接向子弹或副本人员提供的直接资金。 抽象的 RCMI NPR的主要目标是建立神经退行性研究计划（NRP），以增强佛罗里达州A＆M大学研究领域的基础设施，并提高其教师的研究生产力。建立神经退行性研究计划的潜在影响不能被夸大。 神经退行性疾病尤其是对普通大众，尤其是老年人的健康有重大影响。此外，该计划将对增加美国少数族裔神经科学家的数量产生重大影响。 FAMU药房和药学科学学院是全国领先的机构，他在药物科学博士学位和神经科学领域培训非洲裔美国人。因此，本应用程序的目的是通过增加已经存在的人类基础设施和研究资源来开发神经变性研究。长期目标是建立一个专注于神经变性的创新和多学科计划。 具体目的是：1）支持初级FAMU研究者的神经退行性研究试点项目。预计该项目将生成将发布的数据，帮助建立调查员，并允许教师寻求和获得独立研究基金的机会； 2）支持研究设施的发展，以增加神经退行性疾病研究的创新。研究设施将包括：a）分子神经生物学，b）细胞成像和c）神经化学/受体结合； 3）提供内部支持以启动神经退行性研究项目； 4）增强神经退行性研究人员的研究能力，这些研究能力将使他们通过建立内部和外部指导计划竞争主流资金，并以迷你度假，研讨会和工作坊的形式提供培训和学术互动。